GRAIL (Genomic Research in Action to Identify Lung Cancer) is a company focused on early cancer detection using advanced genomic technologies. Specifically, GRAIL aims to develop blood tests that can detect various types of cancer at an early stage, before symptoms appear. The technology leverages large amounts of genetic data to identify markers of cancer presence through a non-invasive blood test, thereby improving chances for successful treatment and patient outcomes.
New to topics? Read the docs here!